Veterinary Medicines

Antastmon 500/100 mg/g Pulver zum Eingeben für Rinder (Kälber), Schweine (Läufer, Ferkel), Pferde (Fohlen), Schafe (Lämmer), Ziegen (Lämmer), Hunde

Authorised
  • Sulfadiazine
  • Trimethoprim
Download as PDF

Product identification

Medicine name:
Antastmon 500/100 mg/g Pulver zum Eingeben für Rinder (Kälber), Schweine (Läufer, Ferkel), Pferde (Fohlen), Schafe (Lämmer), Ziegen (Lämmer), Hunde
Active substance:
  • Sulfadiazine
  • Trimethoprim
Target species:
  • Cattle (calf)
  • Dog
  • Goat (kid)
  • Sheep (lamb)
  • Horse (foal)
  • Pig (piglet)
Route of administration:
  • In-feed use
  • In drinking water use

Product details

Active substance and strength:
  • Sulfadiazine
    500.00
    milligram(s)
    /
    1.00
    gram(s)
  • Trimethoprim
    100.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In-feed use
    • Cattle (calf)
    • Dog
    • Goat (kid)
    • Sheep (lamb)
    • Horse (foal)
    • Pig (piglet)
  • In drinking water use
    • Horse (foal)
    • Dog
    • Goat (kid)
    • Sheep (lamb)
    • Pig (piglet)
    • Cattle (calf)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EW10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6325386.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 6/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."